Cargando…
Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis
The COVID-19 pandemic and the fast global spread of the disease resulted in unprecedented decline in world trade and travel. A critical priority is, therefore, to quickly develop serological diagnostic capacity and identify individuals with past exposure to SARS-CoV-2. In this study serum samples ob...
Autores principales: | Indenbaum, Victoria, Koren, Ravit, Katz-Likvornik, Shiri, Yitzchaki, Mayan, Halpern, Osnat, Regev-Yochay, Gili, Cohen, Carmit, Biber, Asaf, Feferman, Tali, Cohen Saban, Noy, Dhan, Roni, Levin, Tal, Gozlan, Yael, Weil, Merav, Mor, Orna, Mandelboim, Michal, Sofer, Danit, Mendelson, Ella, Lustig, Yaniv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682882/ https://www.ncbi.nlm.nih.gov/pubmed/33227020 http://dx.doi.org/10.1371/journal.pone.0241164 |
Ejemplares similares
-
SARS-CoV-2 outbreak in a synagogue community: longevity and strength of anti-SARS-CoV-2 IgG responses
por: Gozlan, Yael, et al.
Publicado: (2021) -
Immunoglobulin (Ig)A seropositivity against SARS-CoV-2 in healthcare workers in Israel, 4 April to 13 July 2020: an observational study
por: Lustig, Yaniv, et al.
Publicado: (2021) -
Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort study
por: Regev-Yochay, Gili, et al.
Publicado: (2023) -
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron
por: Regev-Yochay, Gili, et al.
Publicado: (2022) -
BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers
por: Lustig, Yaniv, et al.
Publicado: (2021)